nodes	percent_of_prediction	percent_of_DWPC	metapath
Benzonatate—Hallucination, visual—Bromocriptine—type 2 diabetes mellitus	0.0381	0.0431	CcSEcCtD
Benzonatate—Gastrointestinal tract irritation—Glipizide—type 2 diabetes mellitus	0.0331	0.0374	CcSEcCtD
Benzonatate—Eruption—Tolbutamide—type 2 diabetes mellitus	0.0319	0.036	CcSEcCtD
Benzonatate—Eruption—Chlorpropamide—type 2 diabetes mellitus	0.029	0.0327	CcSEcCtD
Benzonatate—Eruption—Tolazamide—type 2 diabetes mellitus	0.029	0.0327	CcSEcCtD
Benzonatate—Nonoxynol-9—PTGS2—type 2 diabetes mellitus	0.0212	1	CrCbGaD
Benzonatate—Eruption—Glipizide—type 2 diabetes mellitus	0.0192	0.0217	CcSEcCtD
Benzonatate—Gastrointestinal tract irritation—Metformin—type 2 diabetes mellitus	0.0191	0.0216	CcSEcCtD
Benzonatate—Eruption—Glimepiride—type 2 diabetes mellitus	0.0179	0.0202	CcSEcCtD
Benzonatate—Eruption—Glyburide—type 2 diabetes mellitus	0.0148	0.0167	CcSEcCtD
Benzonatate—Numbness—Bromocriptine—type 2 diabetes mellitus	0.012	0.0136	CcSEcCtD
Benzonatate—Sensory loss—Bromocriptine—type 2 diabetes mellitus	0.0115	0.013	CcSEcCtD
Benzonatate—SCN5A—Interaction between L1 and Ankyrins—SCN1B—type 2 diabetes mellitus	0.0109	0.117	CbGpPWpGaD
Benzonatate—Numbness—Gliclazide—type 2 diabetes mellitus	0.00986	0.0111	CcSEcCtD
Benzonatate—Sensory loss—Gliclazide—type 2 diabetes mellitus	0.00943	0.0106	CcSEcCtD
Benzonatate—SCN5A—Interaction between L1 and Ankyrins—ANK1—type 2 diabetes mellitus	0.0087	0.0939	CbGpPWpGaD
Benzonatate—Nasal congestion—Bromocriptine—type 2 diabetes mellitus	0.00793	0.00895	CcSEcCtD
Benzonatate—Numbness—Irbesartan—type 2 diabetes mellitus	0.00778	0.00879	CcSEcCtD
Benzonatate—Sensory loss—Irbesartan—type 2 diabetes mellitus	0.00745	0.00841	CcSEcCtD
Benzonatate—Abdominal discomfort—Glipizide—type 2 diabetes mellitus	0.00711	0.00803	CcSEcCtD
Benzonatate—Laryngospasm—Ramipril—type 2 diabetes mellitus	0.00698	0.00787	CcSEcCtD
Benzonatate—Tremor—Nateglinide—type 2 diabetes mellitus	0.00676	0.00763	CcSEcCtD
Benzonatate—Constipation—Miglitol—type 2 diabetes mellitus	0.00665	0.0075	CcSEcCtD
Benzonatate—Abdominal discomfort—Sitagliptin—type 2 diabetes mellitus	0.00662	0.00747	CcSEcCtD
Benzonatate—Abdominal discomfort—Bromocriptine—type 2 diabetes mellitus	0.00599	0.00676	CcSEcCtD
Benzonatate—Hypoaesthesia—Glipizide—type 2 diabetes mellitus	0.00591	0.00667	CcSEcCtD
Benzonatate—Hypoaesthesia—Pioglitazone—type 2 diabetes mellitus	0.00566	0.00639	CcSEcCtD
Benzonatate—Hypoaesthesia—Sitagliptin—type 2 diabetes mellitus	0.0055	0.0062	CcSEcCtD
Benzonatate—Nasal congestion—Metformin—type 2 diabetes mellitus	0.00545	0.00615	CcSEcCtD
Benzonatate—Constipation—Linagliptin—type 2 diabetes mellitus	0.00538	0.00607	CcSEcCtD
Benzonatate—Feeling abnormal—Tolazamide—type 2 diabetes mellitus	0.00524	0.00591	CcSEcCtD
Benzonatate—Constipation—Acarbose—type 2 diabetes mellitus	0.00523	0.0059	CcSEcCtD
Benzonatate—Hypoaesthesia—Bromocriptine—type 2 diabetes mellitus	0.00498	0.00561	CcSEcCtD
Benzonatate—Pruritus—Tolbutamide—type 2 diabetes mellitus	0.00495	0.00558	CcSEcCtD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—PHOX2A—type 2 diabetes mellitus	0.00493	0.0532	CbGpPWpGaD
Benzonatate—Abdominal discomfort—Gliclazide—type 2 diabetes mellitus	0.00492	0.00555	CcSEcCtD
Benzonatate—Rash—Miglitol—type 2 diabetes mellitus	0.0049	0.00553	CcSEcCtD
Benzonatate—Tremor—Glipizide—type 2 diabetes mellitus	0.00484	0.00547	CcSEcCtD
Benzonatate—Nasal congestion—Losartan—type 2 diabetes mellitus	0.00484	0.00546	CcSEcCtD
Benzonatate—Hypersensitivity—Linagliptin—type 2 diabetes mellitus	0.00464	0.00523	CcSEcCtD
Benzonatate—Nausea—Miglitol—type 2 diabetes mellitus	0.00462	0.00521	CcSEcCtD
Benzonatate—Bronchospasm—Orlistat—type 2 diabetes mellitus	0.00458	0.00517	CcSEcCtD
Benzonatate—Tremor—Glimepiride—type 2 diabetes mellitus	0.00452	0.0051	CcSEcCtD
Benzonatate—Hypersensitivity—Acarbose—type 2 diabetes mellitus	0.0045	0.00508	CcSEcCtD
Benzonatate—Pruritus—Tolazamide—type 2 diabetes mellitus	0.0045	0.00508	CcSEcCtD
Benzonatate—Pruritus—Chlorpropamide—type 2 diabetes mellitus	0.0045	0.00508	CcSEcCtD
Benzonatate—Abdominal discomfort—Orlistat—type 2 diabetes mellitus	0.00446	0.00504	CcSEcCtD
Benzonatate—Agitation—Glimepiride—type 2 diabetes mellitus	0.00443	0.005	CcSEcCtD
Benzonatate—Rash—Tolbutamide—type 2 diabetes mellitus	0.00441	0.00497	CcSEcCtD
Benzonatate—Headache—Tolbutamide—type 2 diabetes mellitus	0.00438	0.00494	CcSEcCtD
Benzonatate—Constipation—Repaglinide—type 2 diabetes mellitus	0.00436	0.00492	CcSEcCtD
Benzonatate—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.00434	0.0049	CcSEcCtD
Benzonatate—Confusional state—Glipizide—type 2 diabetes mellitus	0.00425	0.0048	CcSEcCtD
Benzonatate—Dizziness—Tolazamide—type 2 diabetes mellitus	0.00421	0.00475	CcSEcCtD
Benzonatate—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.00421	0.00475	CcSEcCtD
Benzonatate—Convulsion—Glimepiride—type 2 diabetes mellitus	0.00418	0.00472	CcSEcCtD
Benzonatate—SCN5A—L1CAM interactions—SCN1B—type 2 diabetes mellitus	0.00418	0.0451	CbGpPWpGaD
Benzonatate—Pruritus—Nateglinide—type 2 diabetes mellitus	0.00417	0.0047	CcSEcCtD
Benzonatate—Nausea—Tolbutamide—type 2 diabetes mellitus	0.00415	0.00469	CcSEcCtD
Benzonatate—Shock—Glipizide—type 2 diabetes mellitus	0.00415	0.00468	CcSEcCtD
Benzonatate—Nasal congestion—Ramipril—type 2 diabetes mellitus	0.00415	0.00468	CcSEcCtD
Benzonatate—Constipation—Rosiglitazone—type 2 diabetes mellitus	0.00412	0.00465	CcSEcCtD
Benzonatate—Abdominal discomfort—Metformin—type 2 diabetes mellitus	0.00411	0.00464	CcSEcCtD
Benzonatate—Hypoaesthesia—Gliclazide—type 2 diabetes mellitus	0.00408	0.00461	CcSEcCtD
Benzonatate—Rash—Tolazamide—type 2 diabetes mellitus	0.00401	0.00453	CcSEcCtD
Benzonatate—Rash—Chlorpropamide—type 2 diabetes mellitus	0.00401	0.00453	CcSEcCtD
Benzonatate—Agitation—Bromocriptine—type 2 diabetes mellitus	0.004	0.00451	CcSEcCtD
Benzonatate—Headache—Tolazamide—type 2 diabetes mellitus	0.00398	0.0045	CcSEcCtD
Benzonatate—Headache—Chlorpropamide—type 2 diabetes mellitus	0.00398	0.0045	CcSEcCtD
Benzonatate—Confusional state—Glimepiride—type 2 diabetes mellitus	0.00397	0.00448	CcSEcCtD
Benzonatate—Rash—Linagliptin—type 2 diabetes mellitus	0.00397	0.00448	CcSEcCtD
Benzonatate—Headache—Linagliptin—type 2 diabetes mellitus	0.00394	0.00445	CcSEcCtD
Benzonatate—Dizziness—Nateglinide—type 2 diabetes mellitus	0.0039	0.0044	CcSEcCtD
Benzonatate—Shock—Glimepiride—type 2 diabetes mellitus	0.00387	0.00437	CcSEcCtD
Benzonatate—Rash—Acarbose—type 2 diabetes mellitus	0.00385	0.00435	CcSEcCtD
Benzonatate—Nausea—Tolazamide—type 2 diabetes mellitus	0.00378	0.00426	CcSEcCtD
Benzonatate—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.00378	0.00426	CcSEcCtD
Benzonatate—Convulsion—Bromocriptine—type 2 diabetes mellitus	0.00377	0.00426	CcSEcCtD
Benzonatate—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.00376	0.00424	CcSEcCtD
Benzonatate—Tremor—Glyburide—type 2 diabetes mellitus	0.00373	0.00421	CcSEcCtD
Benzonatate—Rash—Nateglinide—type 2 diabetes mellitus	0.00372	0.00419	CcSEcCtD
Benzonatate—Nausea—Acarbose—type 2 diabetes mellitus	0.00363	0.0041	CcSEcCtD
Benzonatate—Constipation—Glipizide—type 2 diabetes mellitus	0.00361	0.00407	CcSEcCtD
Benzonatate—Pruritus—Repaglinide—type 2 diabetes mellitus	0.00361	0.00407	CcSEcCtD
Benzonatate—Confusional state—Bromocriptine—type 2 diabetes mellitus	0.00358	0.00404	CcSEcCtD
Benzonatate—Nausea—Nateglinide—type 2 diabetes mellitus	0.0035	0.00395	CcSEcCtD
Benzonatate—Shock—Bromocriptine—type 2 diabetes mellitus	0.0035	0.00394	CcSEcCtD
Benzonatate—Feeling abnormal—Glipizide—type 2 diabetes mellitus	0.00348	0.00392	CcSEcCtD
Benzonatate—Convulsion—Glyburide—type 2 diabetes mellitus	0.00345	0.00389	CcSEcCtD
Benzonatate—Hypoaesthesia—Metformin—type 2 diabetes mellitus	0.00342	0.00386	CcSEcCtD
Benzonatate—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.00341	0.00385	CcSEcCtD
Benzonatate—Constipation—Sitagliptin—type 2 diabetes mellitus	0.00336	0.00379	CcSEcCtD
Benzonatate—Tremor—Gliclazide—type 2 diabetes mellitus	0.00335	0.00378	CcSEcCtD
Benzonatate—SCN5A—L1CAM interactions—ANK1—type 2 diabetes mellitus	0.00334	0.036	CbGpPWpGaD
Benzonatate—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.00333	0.00376	CcSEcCtD
Benzonatate—Agitation—Gliclazide—type 2 diabetes mellitus	0.00328	0.00371	CcSEcCtD
Benzonatate—Confusional state—Glyburide—type 2 diabetes mellitus	0.00327	0.0037	CcSEcCtD
Benzonatate—SCN5A—L1CAM interactions—LAMA1—type 2 diabetes mellitus	0.00325	0.035	CbGpPWpGaD
Benzonatate—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.00324	0.00366	CcSEcCtD
Benzonatate—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.00323	0.00365	CcSEcCtD
Benzonatate—Hypoaesthesia—Irbesartan—type 2 diabetes mellitus	0.00322	0.00364	CcSEcCtD
Benzonatate—Rash—Repaglinide—type 2 diabetes mellitus	0.00322	0.00363	CcSEcCtD
Benzonatate—Bronchospasm—Ramipril—type 2 diabetes mellitus	0.00321	0.00363	CcSEcCtD
Benzonatate—Headache—Repaglinide—type 2 diabetes mellitus	0.0032	0.00361	CcSEcCtD
Benzonatate—Shock—Glyburide—type 2 diabetes mellitus	0.0032	0.00361	CcSEcCtD
Benzonatate—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.00319	0.0036	CcSEcCtD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—NEUROD1—type 2 diabetes mellitus	0.00318	0.0343	CbGpPWpGaD
Benzonatate—Abdominal discomfort—Ramipril—type 2 diabetes mellitus	0.00313	0.00353	CcSEcCtD
Benzonatate—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.00311	0.00351	CcSEcCtD
Benzonatate—Convulsion—Gliclazide—type 2 diabetes mellitus	0.0031	0.00349	CcSEcCtD
Benzonatate—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00304	0.00343	CcSEcCtD
Benzonatate—Constipation—Bromocriptine—type 2 diabetes mellitus	0.00304	0.00343	CcSEcCtD
Benzonatate—Hypoaesthesia—Losartan—type 2 diabetes mellitus	0.00303	0.00342	CcSEcCtD
Benzonatate—Nausea—Repaglinide—type 2 diabetes mellitus	0.00303	0.00342	CcSEcCtD
Benzonatate—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00302	0.00341	CcSEcCtD
Benzonatate—Pruritus—Glipizide—type 2 diabetes mellitus	0.00299	0.00337	CcSEcCtD
Benzonatate—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.00298	0.00336	CcSEcCtD
Benzonatate—Confusional state—Gliclazide—type 2 diabetes mellitus	0.00294	0.00332	CcSEcCtD
Benzonatate—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.00293	0.0033	CcSEcCtD
Benzonatate—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.0029	0.00327	CcSEcCtD
Benzonatate—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.00289	0.00326	CcSEcCtD
Benzonatate—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00286	0.00323	CcSEcCtD
Benzonatate—Convulsion—Orlistat—type 2 diabetes mellitus	0.00281	0.00317	CcSEcCtD
Benzonatate—Tremor—Metformin—type 2 diabetes mellitus	0.0028	0.00316	CcSEcCtD
Benzonatate—Dizziness—Glipizide—type 2 diabetes mellitus	0.00279	0.00315	CcSEcCtD
Benzonatate—Pruritus—Glimepiride—type 2 diabetes mellitus	0.00279	0.00314	CcSEcCtD
Benzonatate—SCN5A—Cardiac Progenitor Differentiation—PAX6—type 2 diabetes mellitus	0.00272	0.0293	CbGpPWpGaD
Benzonatate—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.00268	0.00302	CcSEcCtD
Benzonatate—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00267	0.00302	CcSEcCtD
Benzonatate—Rash—Glipizide—type 2 diabetes mellitus	0.00266	0.003	CcSEcCtD
Benzonatate—Headache—Glipizide—type 2 diabetes mellitus	0.00264	0.00298	CcSEcCtD
Benzonatate—Tremor—Irbesartan—type 2 diabetes mellitus	0.00264	0.00298	CcSEcCtD
Benzonatate—Shock—Valsartan—type 2 diabetes mellitus	0.00264	0.00297	CcSEcCtD
Benzonatate—Dizziness—Glimepiride—type 2 diabetes mellitus	0.0026	0.00294	CcSEcCtD
Benzonatate—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.0026	0.00293	CcSEcCtD
Benzonatate—Agitation—Irbesartan—type 2 diabetes mellitus	0.00259	0.00293	CcSEcCtD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—KCNQ1—type 2 diabetes mellitus	0.00259	0.0279	CbGpPWpGaD
Benzonatate—Headache—Pioglitazone—type 2 diabetes mellitus	0.00253	0.00286	CcSEcCtD
Benzonatate—Nausea—Glipizide—type 2 diabetes mellitus	0.00251	0.00283	CcSEcCtD
Benzonatate—Constipation—Gliclazide—type 2 diabetes mellitus	0.00249	0.00281	CcSEcCtD
Benzonatate—Tremor—Losartan—type 2 diabetes mellitus	0.00249	0.00281	CcSEcCtD
Benzonatate—Rash—Glimepiride—type 2 diabetes mellitus	0.00248	0.0028	CcSEcCtD
Benzonatate—Rash—Sitagliptin—type 2 diabetes mellitus	0.00248	0.00279	CcSEcCtD
Benzonatate—Headache—Glimepiride—type 2 diabetes mellitus	0.00247	0.00278	CcSEcCtD
Benzonatate—Headache—Sitagliptin—type 2 diabetes mellitus	0.00246	0.00278	CcSEcCtD
Benzonatate—Agitation—Losartan—type 2 diabetes mellitus	0.00244	0.00275	CcSEcCtD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—ECE1—type 2 diabetes mellitus	0.00241	0.026	CbGpPWpGaD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—G6PC—type 2 diabetes mellitus	0.00241	0.026	CbGpPWpGaD
Benzonatate—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.0024	0.00271	CcSEcCtD
Benzonatate—Shock—Metformin—type 2 diabetes mellitus	0.0024	0.00271	CcSEcCtD
Benzonatate—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.00239	0.0027	CcSEcCtD
Benzonatate—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00235	0.00265	CcSEcCtD
Benzonatate—Nausea—Glimepiride—type 2 diabetes mellitus	0.00234	0.00264	CcSEcCtD
Benzonatate—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00233	0.00263	CcSEcCtD
Benzonatate—Pruritus—Glyburide—type 2 diabetes mellitus	0.0023	0.00259	CcSEcCtD
Benzonatate—Constipation—Valsartan—type 2 diabetes mellitus	0.00229	0.00259	CcSEcCtD
Benzonatate—Shock—Irbesartan—type 2 diabetes mellitus	0.00227	0.00256	CcSEcCtD
Benzonatate—Rash—Bromocriptine—type 2 diabetes mellitus	0.00224	0.00253	CcSEcCtD
Benzonatate—Headache—Bromocriptine—type 2 diabetes mellitus	0.00223	0.00251	CcSEcCtD
Benzonatate—Confusional state—Losartan—type 2 diabetes mellitus	0.00218	0.00247	CcSEcCtD
Benzonatate—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.00218	0.00246	CcSEcCtD
Benzonatate—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.00215	0.00242	CcSEcCtD
Benzonatate—Tremor—Ramipril—type 2 diabetes mellitus	0.00213	0.00241	CcSEcCtD
Benzonatate—Shock—Losartan—type 2 diabetes mellitus	0.00213	0.00241	CcSEcCtD
Benzonatate—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00211	0.00238	CcSEcCtD
Benzonatate—Agitation—Ramipril—type 2 diabetes mellitus	0.00209	0.00236	CcSEcCtD
Benzonatate—Constipation—Metformin—type 2 diabetes mellitus	0.00209	0.00235	CcSEcCtD
Benzonatate—Pruritus—Gliclazide—type 2 diabetes mellitus	0.00206	0.00233	CcSEcCtD
Benzonatate—Rash—Glyburide—type 2 diabetes mellitus	0.00205	0.00231	CcSEcCtD
Benzonatate—Headache—Glyburide—type 2 diabetes mellitus	0.00203	0.0023	CcSEcCtD
Benzonatate—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.00201	0.00227	CcSEcCtD
Benzonatate—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.00197	0.00223	CcSEcCtD
Benzonatate—Convulsion—Ramipril—type 2 diabetes mellitus	0.00197	0.00223	CcSEcCtD
Benzonatate—Constipation—Irbesartan—type 2 diabetes mellitus	0.00197	0.00222	CcSEcCtD
Benzonatate—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.00195	0.0022	CcSEcCtD
Benzonatate—Nausea—Glyburide—type 2 diabetes mellitus	0.00193	0.00218	CcSEcCtD
Benzonatate—Dizziness—Gliclazide—type 2 diabetes mellitus	0.00193	0.00218	CcSEcCtD
Benzonatate—SCN5A—Cardiac Progenitor Differentiation—IGF2—type 2 diabetes mellitus	0.00193	0.0208	CbGpPWpGaD
Benzonatate—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.0019	0.00214	CcSEcCtD
Benzonatate—Pruritus—Valsartan—type 2 diabetes mellitus	0.0019	0.00214	CcSEcCtD
Benzonatate—Confusional state—Ramipril—type 2 diabetes mellitus	0.00187	0.00211	CcSEcCtD
Benzonatate—Pruritus—Orlistat—type 2 diabetes mellitus	0.00187	0.00211	CcSEcCtD
Benzonatate—Constipation—Losartan—type 2 diabetes mellitus	0.00185	0.00209	CcSEcCtD
Benzonatate—Rash—Gliclazide—type 2 diabetes mellitus	0.00184	0.00207	CcSEcCtD
Benzonatate—Shock—Ramipril—type 2 diabetes mellitus	0.00183	0.00206	CcSEcCtD
Benzonatate—Headache—Gliclazide—type 2 diabetes mellitus	0.00183	0.00206	CcSEcCtD
Benzonatate—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.00179	0.00201	CcSEcCtD
Benzonatate—Dizziness—Valsartan—type 2 diabetes mellitus	0.00177	0.002	CcSEcCtD
Benzonatate—Dizziness—Orlistat—type 2 diabetes mellitus	0.00175	0.00198	CcSEcCtD
Benzonatate—Nausea—Gliclazide—type 2 diabetes mellitus	0.00173	0.00195	CcSEcCtD
Benzonatate—Pruritus—Metformin—type 2 diabetes mellitus	0.00173	0.00195	CcSEcCtD
Benzonatate—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.0017	0.00191	CcSEcCtD
Benzonatate—Rash—Valsartan—type 2 diabetes mellitus	0.00169	0.00191	CcSEcCtD
Benzonatate—Headache—Valsartan—type 2 diabetes mellitus	0.00168	0.00189	CcSEcCtD
Benzonatate—Rash—Orlistat—type 2 diabetes mellitus	0.00167	0.00188	CcSEcCtD
Benzonatate—Headache—Orlistat—type 2 diabetes mellitus	0.00166	0.00187	CcSEcCtD
Benzonatate—Pruritus—Irbesartan—type 2 diabetes mellitus	0.00163	0.00184	CcSEcCtD
Benzonatate—Dizziness—Metformin—type 2 diabetes mellitus	0.00161	0.00182	CcSEcCtD
Benzonatate—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.0016	0.0018	CcSEcCtD
Benzonatate—Nausea—Valsartan—type 2 diabetes mellitus	0.00159	0.0018	CcSEcCtD
Benzonatate—Constipation—Ramipril—type 2 diabetes mellitus	0.00159	0.00179	CcSEcCtD
Benzonatate—SCN5A—Axon guidance—SCN1B—type 2 diabetes mellitus	0.00158	0.017	CbGpPWpGaD
Benzonatate—Nausea—Orlistat—type 2 diabetes mellitus	0.00157	0.00177	CcSEcCtD
Benzonatate—Rash—Metformin—type 2 diabetes mellitus	0.00154	0.00174	CcSEcCtD
Benzonatate—Pruritus—Losartan—type 2 diabetes mellitus	0.00153	0.00173	CcSEcCtD
Benzonatate—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.00153	0.00173	CcSEcCtD
Benzonatate—Headache—Metformin—type 2 diabetes mellitus	0.00153	0.00172	CcSEcCtD
Benzonatate—Dizziness—Irbesartan—type 2 diabetes mellitus	0.00152	0.00172	CcSEcCtD
Benzonatate—SCN5A—Developmental Biology—MAFA—type 2 diabetes mellitus	0.00149	0.016	CbGpPWpGaD
Benzonatate—Rash—Irbesartan—type 2 diabetes mellitus	0.00145	0.00164	CcSEcCtD
Benzonatate—Nausea—Metformin—type 2 diabetes mellitus	0.00145	0.00164	CcSEcCtD
Benzonatate—Headache—Irbesartan—type 2 diabetes mellitus	0.00144	0.00163	CcSEcCtD
Benzonatate—Dizziness—Losartan—type 2 diabetes mellitus	0.00143	0.00162	CcSEcCtD
Benzonatate—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.00137	0.00154	CcSEcCtD
Benzonatate—Nausea—Irbesartan—type 2 diabetes mellitus	0.00137	0.00154	CcSEcCtD
Benzonatate—Rash—Losartan—type 2 diabetes mellitus	0.00137	0.00154	CcSEcCtD
Benzonatate—SCN5A—Developmental Biology—NKX6-1—type 2 diabetes mellitus	0.00136	0.0147	CbGpPWpGaD
Benzonatate—Headache—Losartan—type 2 diabetes mellitus	0.00136	0.00153	CcSEcCtD
Benzonatate—SCN5A—Axon guidance—TRPC1—type 2 diabetes mellitus	0.00134	0.0145	CbGpPWpGaD
Benzonatate—Pruritus—Ramipril—type 2 diabetes mellitus	0.00131	0.00148	CcSEcCtD
Benzonatate—Nausea—Losartan—type 2 diabetes mellitus	0.00129	0.00145	CcSEcCtD
Benzonatate—SCN5A—Cardiac Progenitor Differentiation—INS—type 2 diabetes mellitus	0.00128	0.0138	CbGpPWpGaD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—CPT1A—type 2 diabetes mellitus	0.00127	0.0136	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—NEUROD1—type 2 diabetes mellitus	0.00126	0.0136	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—ANK1—type 2 diabetes mellitus	0.00126	0.0136	CbGpPWpGaD
Benzonatate—SCN5A—Cardiac Progenitor Differentiation—IGF1—type 2 diabetes mellitus	0.00124	0.0133	CbGpPWpGaD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—GCK—type 2 diabetes mellitus	0.00123	0.0133	CbGpPWpGaD
Benzonatate—Dizziness—Ramipril—type 2 diabetes mellitus	0.00123	0.00139	CcSEcCtD
Benzonatate—SCN5A—Axon guidance—LAMA1—type 2 diabetes mellitus	0.00123	0.0132	CbGpPWpGaD
Benzonatate—Rash—Ramipril—type 2 diabetes mellitus	0.00117	0.00132	CcSEcCtD
Benzonatate—Headache—Ramipril—type 2 diabetes mellitus	0.00116	0.00131	CcSEcCtD
Benzonatate—SCN5A—Developmental Biology—SCN1B—type 2 diabetes mellitus	0.00113	0.0122	CbGpPWpGaD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—SNAP25—type 2 diabetes mellitus	0.00111	0.0119	CbGpPWpGaD
Benzonatate—Nausea—Ramipril—type 2 diabetes mellitus	0.0011	0.00125	CcSEcCtD
Benzonatate—SCN5A—Developmental Biology—PAX4—type 2 diabetes mellitus	0.000958	0.0103	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—TRPC1—type 2 diabetes mellitus	0.000958	0.0103	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—ANK1—type 2 diabetes mellitus	0.0009	0.00971	CbGpPWpGaD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—GJA1—type 2 diabetes mellitus	0.000884	0.00954	CbGpPWpGaD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—AR—type 2 diabetes mellitus	0.000877	0.00946	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—LAMA1—type 2 diabetes mellitus	0.000876	0.00945	CbGpPWpGaD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—GNB3—type 2 diabetes mellitus	0.000826	0.00892	CbGpPWpGaD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—PPARGC1A—type 2 diabetes mellitus	0.000826	0.00892	CbGpPWpGaD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—AVP—type 2 diabetes mellitus	0.000815	0.0088	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—HNF1A—type 2 diabetes mellitus	0.000814	0.00879	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—PDX1—type 2 diabetes mellitus	0.000814	0.00879	CbGpPWpGaD
Benzonatate—SCN5A—Cardiac Progenitor Differentiation—TGFB1—type 2 diabetes mellitus	0.000741	0.00799	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—NCOA6—type 2 diabetes mellitus	0.000738	0.00796	CbGpPWpGaD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—NR3C1—type 2 diabetes mellitus	0.000709	0.00765	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—PCK1—type 2 diabetes mellitus	0.000682	0.00736	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—TRPC6—type 2 diabetes mellitus	0.000667	0.00719	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—HNF1B—type 2 diabetes mellitus	0.000664	0.00716	CbGpPWpGaD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—HIF1A—type 2 diabetes mellitus	0.000646	0.00697	CbGpPWpGaD
Benzonatate—SCN5A—L1CAM interactions—SRC—type 2 diabetes mellitus	0.000515	0.00556	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—SLC2A2—type 2 diabetes mellitus	0.000514	0.00554	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—HNF4A—type 2 diabetes mellitus	0.000503	0.00543	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—GCK—type 2 diabetes mellitus	0.00049	0.00529	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—IAPP—type 2 diabetes mellitus	0.000487	0.00526	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—TRPC6—type 2 diabetes mellitus	0.000476	0.00513	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—PAX6—type 2 diabetes mellitus	0.000455	0.00491	CbGpPWpGaD
Benzonatate—SCN5A—L1CAM interactions—EGFR—type 2 diabetes mellitus	0.000452	0.00487	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—SREBF1—type 2 diabetes mellitus	0.00044	0.00474	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—ADIPOQ—type 2 diabetes mellitus	0.000404	0.00436	CbGpPWpGaD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	0.000401	0.00433	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—SLC2A4—type 2 diabetes mellitus	0.000381	0.00411	CbGpPWpGaD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	0.000375	0.00405	CbGpPWpGaD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	0.00034	0.00367	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—PPARGC1A—type 2 diabetes mellitus	0.000329	0.00355	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—LPL—type 2 diabetes mellitus	0.000299	0.00323	CbGpPWpGaD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	0.000292	0.00315	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—CD36—type 2 diabetes mellitus	0.000284	0.00307	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—PPARA—type 2 diabetes mellitus	0.000264	0.00285	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—LEP—type 2 diabetes mellitus	0.000251	0.00271	CbGpPWpGaD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	0.000235	0.00254	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—PPARG—type 2 diabetes mellitus	0.000218	0.00236	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—INS—type 2 diabetes mellitus	0.000214	0.00231	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—MMP9—type 2 diabetes mellitus	0.000211	0.00228	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—AKT2—type 2 diabetes mellitus	0.000207	0.00223	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—SRC—type 2 diabetes mellitus	0.000195	0.0021	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—VEGFA—type 2 diabetes mellitus	0.00019	0.00205	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—RELA—type 2 diabetes mellitus	0.000177	0.00191	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—EGFR—type 2 diabetes mellitus	0.000171	0.00184	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—MMP9—type 2 diabetes mellitus	0.000151	0.00163	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—NFKB1—type 2 diabetes mellitus	0.000149	0.00161	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—SRC—type 2 diabetes mellitus	0.000139	0.0015	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—VEGFA—type 2 diabetes mellitus	0.000135	0.00146	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—IL6—type 2 diabetes mellitus	0.000131	0.00142	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—TGFB1—type 2 diabetes mellitus	0.000124	0.00134	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—EGFR—type 2 diabetes mellitus	0.000122	0.00131	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—TNF—type 2 diabetes mellitus	0.000116	0.00125	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—IL6—type 2 diabetes mellitus	9.36e-05	0.00101	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—AKT1—type 2 diabetes mellitus	8.64e-05	0.000932	CbGpPWpGaD
